Back to Screener

Translational Development Acquisition Corp. Warrants (TDACW)

Price$0.12

Favorite Metrics

Price vs S&P 500 (4W)-61.00%

All Metrics

Price vs S&P 500 (YTD)-57.04%
10-Day Avg Trading Volume0.01M
3-Month Avg Trading Volume0.01M
52-Week High$0.42
13-Week Price Return-52.00%
3-Month Return Std Dev130.05%
Year-to-Date Return-61.29%
5-Day Price Return-29.41%
Month-to-Date Return-44.73%
Price vs S&P 500 (13W)-48.51%
52-Week Low$0.12

Industry Peers — Blank Checks / SPACs(334)

SymbolP/E Ratio (Annual)Indicated Dividend Yield (Annual)ROE (TTM)P/B Ratio (Quarterly)Price
TDACWTranslational Development Acquisition Corp. Warrants
$0.12
LFACLeapfrog Acquisition Corporation Class A Ordinary Shares
742.60x1.92%2.80x$9.95
LFACULeapfrog Acquisition Corporation Units
720.81x1.92%2.80x$10.04
AACIArmada Acquisition Corp. III Class A Ordinary Share
-9.52%14.61x$9.90
BEAGBold Eagle Acquisition Corp. Class A Ordinary Shares
61.97x3.80%2.33x$10.53
BEAGRBold Eagle Acquisition Corp. Right
61.97x3.80%2.33x$0.24
BEAGUBold Eagle Acquisition Corp. Units
61.97x3.80%2.33x$10.74
BCSSBain Capital GSS Investment Corp.
139.43x1.31x$10.18
BCSS.UBain Capital GSS Investment Corp. Units, each consisting of one Class A Ordinary Share and one-fifth of one redeemable warrant
139.43x1.31x$10.39
CEPFCantor Equity Partners IV, Inc. Class A Ordinary Shares
95.72x1.29x$10.26
KRSPRice Acquisition Corporation 3
172.51x1.41x$10.30

About

Translational Development Acquisition Corp is a blank check company formed to acquire, merge with, or otherwise combine with an operating business. The company has not yet identified a specific target acquisition. As a SPAC, investors should be aware that the company's value is dependent on the success of its future acquisition and business combination.